Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Free University of Brussels

Headquarters: Brussels, Belgium
Year Founded: 1834
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Aug 11, 2023
Discovery & Translation

Bacteria to detect tumors; plus Netris’ mAb to block EMT in cancer and more

BioCentury’s roundup of translational innovations
BioCentury | Sep 21, 2022
Management Tracks

New CEOs at Scholar Rock, Neuway, NeuVasQ and ProLynx

Plus Serono’s Maria Rivas joins Pfizer, and updates from 
BioCentury | Feb 18, 2022
Discovery & Translation

Engineered Wnt ligand restores BBB; plus Codiak, Autotac and more

BioCentury’s roundup of translational news
BioCentury | Oct 11, 2018
Distillery Therapeutics

Cancer

BioCentury | Nov 28, 2017
Distillery Techniques

Biomarkers

BioCentury | May 2, 2013
Distillery Therapeutics

Indication: Various

BioCentury | Oct 25, 2012
Distillery Therapeutics

Indication: Hematology

BioCentury | Oct 18, 2012
Distillery Therapeutics

Indication: Endocrine/metabolic disease

Items per page:
1 - 10 of 23